We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has approved Ketek, the first in a new class of antibiotics known as ketolides that are designed to target respiratory pathogens including those that are antibiotic-resistant, according to the drug’s manufacturer Aventis.